Top Page
Benchmark Holdings
(LSE:BMK)
Benchmark Holdings (BMK) vs. iShares MSCI United Kingdom ETF (EWC)
Benchmark Holdings Business Overview & Revenue Model
Benchmark Holdings Financial Statement Overview
| Breakdown | TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.61M | 90.36M | 169.48M | 158.28M | 125.06M | 105.56M |
| Gross Profit | 25.62M | 43.95M | 86.75M | 83.13M | 65.58M | 54.96M |
| EBITDA | 5.78M | 3.96M | 34.20M | 28.35M | 24.36M | 14.34M |
| Net Income | -41.76M | -39.46M | -23.15M | -30.45M | -11.58M | -22.77M |
Balance Sheet | ||||||
| Total Assets | 380.77M | 384.90M | 471.30M | 526.57M | 481.99M | 489.04M |
| Cash, Cash Equivalents and Short-Term Investments | 13.81M | 23.09M | 36.52M | 36.40M | 39.46M | 71.61M |
| Total Debt | 75.84M | 72.07M | 102.00M | 110.14M | 120.39M | 109.16M |
| Total Liabilities | 155.33M | 160.63M | 188.68M | 203.29M | 202.39M | 193.59M |
| Stockholders Equity | 219.74M | 218.26M | 276.40M | 313.40M | 271.71M | 289.13M |
Cash Flow | ||||||
| Free Cash Flow | -6.50M | -1.92M | 13.22M | -1.91M | -16.93M | -15.47M |
| Operating Cash Flow | -2.72M | 2.00M | 20.00M | 10.81M | 5.79M | -4.06M |
| Investing Cash Flow | -2.81M | -2.83M | -5.27M | -11.22M | -23.09M | 30.38M |
| Financing Cash Flow | -4.05M | -10.97M | -12.33M | -6.92M | -14.67M | 30.13M |
Benchmark Holdings Technical Analysis
Benchmark Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | £203.52M | 5.60 | 33.70% | 1.51% | -0.17% | 2591.96% | |
62 Neutral | £41.67M | 61.86 | 0.80% | ― | -4.37% | ― | |
59 Neutral | £5.93B | 9.05 | -57.69% | 4.70% | 15.15% | -8.16% | |
55 Neutral | £184.12M | ― | ― | ― | ― | ||
53 Neutral | £381.32M | ― | -369.20% | ― | 4.50% | 74.32% |
Benchmark Holdings Corporate Events
Benchmark Holdings has announced the approval of its proposals to return the majority of net proceeds from the sale of its Genetics Business to shareholders, delist from AIM and Euronext Growth Oslo, and re-register as a private limited company. The tender offer will open on July 3, 2025, and the delisting from Euronext Growth Oslo is expected to follow the completion of the tender offer. These strategic moves are aimed at streamlining operations and focusing on core business areas, potentially impacting shareholders and market positioning.
Benchmark Holdings PLC, a company involved in the aquaculture industry, announced that its total issued share capital now consists of 742,423,113 ordinary shares, all with voting rights. This increase in share capital is attributed to the routine exercise of options by current and former employees under the company’s block admission, impacting the calculation of shareholder interests.
Benchmark Holdings PLC, a company involved in the aquaculture industry, announced that as of June 30, 2025, its total issued share capital consists of 742,423,113 ordinary shares, all with voting rights. This increase in share capital is attributed to the routine exercise of options by current and former employees under the company’s block admission. The updated share capital figure will be used by shareholders to determine their interest or changes in their interest in the company.
Benchmark Holdings announced that all resolutions at their General Meeting were approved, including a tender offer, de-listing, and re-registration. This approval signifies strong shareholder support and could impact the company’s strategic direction and market presence. Additionally, the company was informed of a recapitalization arrangement involving Mavenir Systems Inc., where the Chair of Benchmark, Nathan ‘Tripp’ Lane, is a board director.
Benchmark Holdings reported a £76 million profit for the first half of 2025, primarily driven by the £90.9 million gain from the sale of its Genetics business. The company plans to return capital to shareholders and delist from AIM and Euronext Growth Oslo. Despite a 22% decline in group revenues from continuing activities, the company has shown improvements in Advanced Nutrition and maintained solid performance in its Health segment. The restructuring following the Genetics sale is expected to streamline operations and reduce costs, positioning Benchmark for future growth. The company is also preparing for the relaunch of Ectosan® Vet and CleanTreat® with a new land-based model.
Benchmark Holdings plc has announced a change in the timing of its Equity Development webcast for retail investors, which will now occur at 10.00am UK time on Thursday, 12 June 2025. This webcast is part of the company’s release of its unaudited interim results for the six-month period ending 31 March 2025. The change in schedule reflects the company’s commitment to engaging with its investors and stakeholders, potentially impacting investor relations and market perception.
Benchmark Holdings plc has announced that it will release its unaudited interim results for the six-month period ending 31 March 2025 on 12 June 2025. The announcement will be accompanied by presentations for analysts, institutional investors, retail investors, and wealth managers, indicating the company’s commitment to transparency and engagement with its stakeholders.
Benchmark Holdings PLC has announced a series of proposals following the disposal of its Genetics Business, including the return of capital to shareholders and the cancellation of its shares from trading on AIM and Euronext Growth Oslo. The company plans to re-register as a private limited company and offer a tender for shareholders to realize their investments, with a special dividend planned post-tender. These moves aim to streamline operations and focus on future growth, with implications for shareholder structure and market presence.
Benchmark Holdings PLC announced that as of 30 April 2025, its issued share capital consists of 741,505,672 ordinary shares, all with voting rights. This figure has remained unchanged since the previous announcement on 31 March 2025, and shareholders can use this number to calculate their interest in the company. This stability in share capital indicates a steady state in the company’s financial structure, which could reassure investors and stakeholders about the company’s current market position.
Benchmark Holdings has announced the completion of its Green Bond redemption and repayment of its RCF, making the company debt-free. The company has also streamlined its corporate structure following the sale of its Genetics division, preparing for its next phase of operations. Details on the strategy for continuing business and return of capital are expected in May, signaling a strategic shift that could impact its market positioning and stakeholder interests.